Revealing alcohol abuse: To ask or to test?

被引：13
作者：
Alling, C
Chick, JD
Anton, R
Mayfield, RD
Salaspuro, M
Helander, A
Harris, RA
机构：
[1] Univ Texas, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA
[2] Univ Lund Hosp, Dept Lab Med, S-22185 Lund, Sweden
[3] Univ Edinburgh, Dept Psychiat, Edinburgh EH8 9YL, Midlothian, Scotland
[4] Med Univ S Carolina, Ctr Drug & Alcohol Programs, Charleston, SC 29425 USA
[5] Univ Helsinki, Res Unit Subst Aduse Med, FIN-00014 Helsinki, Finland
[6] Karolinska Inst, Stockholm, Sweden
[7] Univ Hosp, Alcohol Lab, Stockholm, Sweden
来源：
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | 2005年 / 29卷 / 07期
关键词：
biomarker; genomic; proteomic; alcoholism; alcohol abuse;
D O I：
10.1097/01.ALC.0000171489.55856.A5
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
This article represents the proceedings of a symposium at the 2004 ISBRA Congress in Heidelberg/Mannheim, Germany. The chairs were C. Alling and R. A. Harris. The presentations were (1) Advantage and Disadvantage of Tests for Self-Reported Intake in Different Settings, by J. D. Chick; (2) Update on the Use of Biological Markers to Monitor Outcome in Alcoholism Clinical Treatment Trials, by R. Anton; (3) Identification of Alcohol Biomarkers Using Genomic and Proteomic Approaches, by R. D. Mayfield; (4) Use of Biomarkers as Secondary or Primary Outcome Measures in Alcoholism Treatment Trials, by M. Salaspuro; and (5) Use of Tests for Drink-Drive Offenders: A European Perspective, by A. Helander.
引用
收藏
页码：1257 / 1263
页数：7
相关论文
共 46 条
[1]  
Aertgeerts B, 2001, BRIT J GEN PRACT, V51, P206
[2]  
Allen JP, 2001, ALCOHOL CLIN EXP RES, V25, P1119
[3]   Laboratory markers carbohydrate-deficient transferrin, γ-glutamyltransferase, and mean corpuscular volume are not useful as screening tools for high-risk drinking in the general population:: Results from the study of health in Pomerania (SHIP) [J].
Alte, D ;
Luedemann, J ;
Rose, HJ ;
John, U .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (06) :931-940
[4]   A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence [J].
Anton, RF ;
Pettinati, H ;
Zweben, A ;
Kranzler, HR ;
Johnson, B ;
Bohn, MJ ;
McCaul, ME ;
Anthenelli, R ;
Salloum, I ;
Galloway, G ;
Garbutt, J ;
Swift, R ;
Gastfriend, D ;
Kallio, A ;
Karhuvaara, S .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (04) :421-428
[5]   Carbohydrate-deficient transferrin and γ-glutamyltransferase for the detection and monitoring of alcohol use:: Results from a multisite study [J].
Anton, RF ;
Lieber, C ;
Tabakoff, B .
ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2002, 26 (08) :1215-1222
[6]   CARBOHYDRATE-DEFICIENT TRANSFERRIN AND GAMMA-GLUTAMYL-TRANSFERASE AS MARKERS OF HEAVY ALCOHOL-CONSUMPTION - GENDER DIFFERENCES [J].
ANTON, RF ;
MOAK, DH .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1994, 18 (03) :747-754
[7]  
ANTON RF, 2005, IN PRESS J CLIN PSYC
[8]   5-Hydroxytryptophol as a marker for recent alcohol intake [J].
Beck, O ;
Helander, A .
ADDICTION, 2003, 98 :63-72
[9]   Possibility of improving the acceptance rate of early detection testing for prostate cancer with a one-step test for prostate-specific antigen in whole blood [J].
Berg, W ;
Linder, C ;
Eschholz, G ;
Link, S ;
Schubert, J .
UROLOGIA INTERNATIONALIS, 1999, 63 (02) :102-106
[10]   A diagnostic test for prostate cancer from gene expression profiling data [J].
Bueno, R ;
Loughlin, KR ;
Powell, MH ;
Gordon, GJ .
JOURNAL OF UROLOGY, 2004, 171 (02) :903-906
12345